QIAGEN N.V. (QGEN) Stock Fundamental Analysis
NYSE:QGEN • NL0015002SN0
48.62 USD
+0.12 (+0.25%)
At close: Feb 25, 2026
48.61 USD
-0.01 (-0.02%)
Pre-Market: 2/26/2026, 6:56:33 AM
We assign a fundamental rating of 6 out of 10 to QGEN. QGEN was compared to 58 industry peers in the Life Sciences Tools & Services industry. QGEN has an excellent profitability rating, but there are some minor concerns on its financial health. QGEN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year QGEN was profitable.
- QGEN had a positive operating cash flow in the past year.
- QGEN had positive earnings in each of the past 5 years.
- Each year in the past 5 years QGEN had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of QGEN (6.75%) is better than 84.48% of its industry peers.
- With an excellent Return On Equity value of 11.25%, QGEN belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
- QGEN's Return On Invested Capital of 7.23% is fine compared to the rest of the industry. QGEN outperforms 79.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.75% | ||
| ROE | 11.25% | ||
| ROIC | 7.23% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 20.33%, QGEN belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
- In the last couple of years the Profit Margin of QGEN has remained more or less at the same level.
- Looking at the Operating Margin, with a value of 25.69%, QGEN belongs to the top of the industry, outperforming 94.83% of the companies in the same industry.
- In the last couple of years the Operating Margin of QGEN has declined.
- QGEN's Gross Margin of 62.97% is amongst the best of the industry. QGEN outperforms 84.48% of its industry peers.
- In the last couple of years the Gross Margin of QGEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.69% | ||
| PM (TTM) | 20.33% | ||
| GM | 62.97% |
OM growth 3Y-2.56%
OM growth 5Y-2.83%
PM growth 3Y0.95%
PM growth 5Y1.14%
GM growth 3Y-1.29%
GM growth 5Y-1.16%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QGEN is destroying value.
- QGEN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- QGEN has an Altman-Z score of 3.89. This indicates that QGEN is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.89, QGEN is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
- The Debt to FCF ratio of QGEN is 3.70, which is a good value as it means it would take QGEN, 3.70 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of QGEN (3.70) is better than 74.14% of its industry peers.
- QGEN has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
- QGEN has a Debt to Equity ratio of 0.44. This is in the lower half of the industry: QGEN underperforms 60.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 3.7 | ||
| Altman-Z | 3.89 |
ROIC/WACC0.85
WACC8.49%
2.3 Liquidity
- QGEN has a Current Ratio of 3.90. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
- QGEN has a Current ratio (3.90) which is comparable to the rest of the industry.
- A Quick Ratio of 3.31 indicates that QGEN has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.31, QGEN is in the better half of the industry, outperforming 63.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.9 | ||
| Quick Ratio | 3.31 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 10.63% over the past year.
- Measured over the past 5 years, QGEN shows a small growth in Earnings Per Share. The EPS has been growing by 1.64% on average per year.
- QGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.65%.
- QGEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.25% yearly.
EPS 1Y (TTM)10.63%
EPS 3Y-0.54%
EPS 5Y1.64%
EPS Q2Q%1.64%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y-0.81%
Revenue growth 5Y2.25%
Sales Q2Q%3.69%
3.2 Future
- Based on estimates for the next years, QGEN will show a small growth in Earnings Per Share. The EPS will grow by 7.28% on average per year.
- QGEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.44% yearly.
EPS Next Y8.94%
EPS Next 2Y9.23%
EPS Next 3Y8.78%
EPS Next 5Y7.28%
Revenue Next Year6.28%
Revenue Next 2Y6.2%
Revenue Next 3Y7.56%
Revenue Next 5Y7.44%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 19.68, which indicates a rather expensive current valuation of QGEN.
- QGEN's Price/Earnings ratio is rather cheap when compared to the industry. QGEN is cheaper than 84.48% of the companies in the same industry.
- QGEN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 18.05, which indicates a rather expensive current valuation of QGEN.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of QGEN indicates a rather cheap valuation: QGEN is cheaper than 84.48% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 28.03, QGEN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.68 | ||
| Fwd PE | 18.05 |
4.2 Price Multiples
- QGEN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QGEN is cheaper than 87.93% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, QGEN is valued a bit cheaper than the industry average as 77.59% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.4 | ||
| EV/EBITDA | 14.11 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of QGEN may justify a higher PE ratio.
PEG (NY)2.2
PEG (5Y)12.02
EPS Next 2Y9.23%
EPS Next 3Y8.78%
5. Dividend
5.1 Amount
- QGEN has a yearly dividend return of 0.52%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.10, QGEN pays a better dividend. On top of this QGEN pays more dividend than 93.10% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.80, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
5.2 History
- QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- QGEN pays out 12.77% of its income as dividend. This is a sustainable payout ratio.
DP12.77%
EPS Next 2Y9.23%
EPS Next 3Y8.78%
48.62
+0.12 (+0.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)05-05 2026-05-05/amc
Inst Owners85.46%
Inst Owner Change-99.66%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap10.02B
Revenue(TTM)2.09B
Net Income(TTM)424.88M
Analysts71.67
Price Target54.71 (12.53%)
Short Float %N/A
Short Ratio2.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP12.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.46%
Min EPS beat(2)-3.03%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)1.12%
Min EPS beat(4)-3.03%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.49%
EPS beat(12)7
Avg EPS beat(12)1.45%
EPS beat(16)11
Avg EPS beat(16)3.7%
Revenue beat(2)0
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.31%
Revenue beat(4)1
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.72%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)1
Avg Revenue beat(12)-0.7%
Revenue beat(16)5
Avg Revenue beat(16)-0.05%
PT rev (1m)0.99%
PT rev (3m)5.02%
EPS NQ rev (1m)-2.46%
EPS NQ rev (3m)-2.44%
EPS NY rev (1m)-0.28%
EPS NY rev (3m)3.79%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.68 | ||
| Fwd PE | 18.05 | ||
| P/S | 4.79 | ||
| P/FCF | 22.4 | ||
| P/OCF | 15.31 | ||
| P/B | 2.65 | ||
| P/tB | 14.49 | ||
| EV/EBITDA | 14.11 |
EPS(TTM)2.47
EY5.08%
EPS(NY)2.69
Fwd EY5.54%
FCF(TTM)2.17
FCFY4.46%
OCF(TTM)3.18
OCFY6.53%
SpS10.15
BVpS18.34
TBVpS3.35
PEG (NY)2.2
PEG (5Y)12.02
Graham Number31.93
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.75% | ||
| ROE | 11.25% | ||
| ROCE | 9.28% | ||
| ROIC | 7.23% | ||
| ROICexc | 8.92% | ||
| ROICexgc | 26.15% | ||
| OM | 25.69% | ||
| PM (TTM) | 20.33% | ||
| GM | 62.97% | ||
| FCFM | 21.4% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.56%
OM growth 5Y-2.83%
PM growth 3Y0.95%
PM growth 5Y1.14%
GM growth 3Y-1.29%
GM growth 5Y-1.16%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 3.7 | ||
| Debt/EBITDA | 2.26 | ||
| Cap/Depr | 106.91% | ||
| Cap/Sales | 9.91% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 89.55% | ||
| Profit Quality | 105.25% | ||
| Current Ratio | 3.9 | ||
| Quick Ratio | 3.31 | ||
| Altman-Z | 3.89 |
F-Score6
WACC8.49%
ROIC/WACC0.85
Cap/Depr(3y)90.15%
Cap/Depr(5y)87.64%
Cap/Sales(3y)8.95%
Cap/Sales(5y)8.6%
Profit Quality(3y)264.36%
Profit Quality(5y)202.24%
High Growth Momentum
Growth
EPS 1Y (TTM)10.63%
EPS 3Y-0.54%
EPS 5Y1.64%
EPS Q2Q%1.64%
EPS Next Y8.94%
EPS Next 2Y9.23%
EPS Next 3Y8.78%
EPS Next 5Y7.28%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y-0.81%
Revenue growth 5Y2.25%
Sales Q2Q%3.69%
Revenue Next Year6.28%
Revenue Next 2Y6.2%
Revenue Next 3Y7.56%
Revenue Next 5Y7.44%
EBIT growth 1Y8.48%
EBIT growth 3Y-3.35%
EBIT growth 5Y-0.65%
EBIT Next Year39.81%
EBIT Next 3Y18.07%
EBIT Next 5Y12.48%
FCF growth 1Y-10.97%
FCF growth 3Y-7.55%
FCF growth 5Y23.83%
OCF growth 1Y-2.85%
OCF growth 3Y-2.92%
OCF growth 5Y7.4%
QIAGEN N.V. / QGEN FAQ
Can you provide the ChartMill fundamental rating for QIAGEN N.V.?
ChartMill assigns a fundamental rating of 6 / 10 to QGEN.
Can you provide the valuation status for QIAGEN N.V.?
ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QGEN). This can be considered as Fairly Valued.
What is the profitability of QGEN stock?
QIAGEN N.V. (QGEN) has a profitability rating of 7 / 10.
What is the earnings growth outlook for QIAGEN N.V.?
The Earnings per Share (EPS) of QIAGEN N.V. (QGEN) is expected to grow by 8.94% in the next year.
Can you provide the dividend sustainability for QGEN stock?
The dividend rating of QIAGEN N.V. (QGEN) is 3 / 10 and the dividend payout ratio is 12.77%.